From hard tissues to beyond: Progress and challenges of strontium-containing biomaterials in regenerative medicine applications
Source abstract
Abstract
Tissue engineering and regenerative medicine have emerged as crucial disciplines focused on the development of new tissues and organs to overcome the limitations of traditional treatments for tissue damage caused by accidents, diseases, or aging. Strontium ion (Sr2+) has garnered significant attention for its multifaceted role in promoting regeneration medicine and therapy, especially in bone tissue regeneration. Recently, numerous studies further confirm that Sr2+ also plays a critical in soft tissue regeneration. This review firstly summarizes the influence of Sr2+ on critical biological processes such as osteogenesis, angiogenesis, immune modulation, matrix synthesis, mineralization, and antioxidative defence mechanisms. Then details the classification, properties, advantages, and limitations of Sr-containing biomaterials (SrBMs). Additionally, this review extends to the current applications of SrBMs in regenerative medicine for diverse tissues, including bone, cartilage, skeletal muscle, dental pulp, cardiac tissue, skin, hair follicles, etc. Moreover, the review addresses the challenges associated with current SrBMs and provides insights for their future designing and applications in regenerative medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Developing fibrin-based biomaterials/scaffolds in tissue engineering
2. Functional acellular matrix for tissue repair
3. Hypoxic microenvironment reconstruction with synergistic biofunctional ions promotes diabetic wound healing10.1002/adhm.202301984 ↗
4. Hematoma-like dynamic hydrogelation through natural glycopeptide molecular recognition for infected bone fracture repair
5. Chemically programmed hydrogels for spatiotemporal modulation of the cardiac pathological microenvironment
6. Impact of metal ions on cellular functions: a focus on mesenchymal stem/stromal cell differentiation10.3390/ijms251810127 ↗
7. A sequential macrophage activation strategy for bone regeneration: a micro/nano strontium-releasing composite scaffold loaded with lipopolysaccharide
8. Spontaneous immunomodulation and regulation of angiogenesis and osteogenesis by Sr/Cu-borosilicate glass (BSG) bone cement to repair critical bone defects
9. Strontium (Sr) strengthens the silicon (Si) upon osteoblast proliferation, osteogenic differentiation and angiogenic factor expression10.1039/C6TB00735J ↗
10. Enhanced tissue infiltration and bone regeneration through spatiotemporal delivery of bioactive factors from polyelectrolytes modified biomimetic scaffold
11. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response10.1007/s00198-008-0728-6 ↗
12. Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/β-catenin signaling pathway in alveolar bone of ovariectomized rats10.1007/s11596-014-1241-0 ↗
13. Nanorod diameter modulated osteogenic activity of hierarchical micropore/nanorod-patterned coatings via a Wnt/β-catenin pathway10.1016/j.nano.2018.04.006 ↗
14. Endothelial progenitor cells promote viability and nerve regenerative ability of mesenchymal stem cells through PDGF-BB/PDGFR-β signaling10.18632/aging.102604 ↗
15. Strontium-doped hydroxyapatite coating improves osteo/angiogenesis for ameliorative graft-bone integration via the macrophage-derived cytokines-mediated integrin signal pathway10.1021/acsami.3c14904 ↗
16. Propelling minimally invasive tissue regeneration with next-era injectable pre-formed scaffolds10.1002/adma.202400700 ↗
17. Electroactive biomaterials and systems for cell fate determination and tissue regeneration: design and applications
18. Bioactive materials for in vivo sweat gland regeneration
19. Biomaterials for drug delivery and human applications10.3390/ma17020456 ↗
20. Advances in modification methods based on biodegradable membranes in guided bone/tissue regeneration: a review10.3390/polym14050871 ↗
21. Biomaterial scaffolds in maxillofacial bone tissue engineering: a review of recent advances
22. Fabrication and performance of Zinc-based biodegradable metals: from conventional processes to laser powder bed fusion
23. Preparation and characterization of Sr-hardystonite (Sr2ZnSi2O7) for bone repair applications10.1016/j.msec.2011.10.017 ↗
24. Materials strategies to overcome the foreign body response10.1002/adhm.202304478 ↗
25. Ion-doped brushite cements for bone regeneration10.1016/j.actbio.2021.01.004 ↗
26. Mesoporous bioactive glasses for regenerative medicine
27. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide10.1055/s-0029-1192035 ↗
28. Advanced applications of strontium-containing biomaterials in bone tissue engineering
29. Strontium-substituted sub-micron bioactive glasses inhibit ostoclastogenesis through suppression of RANKL-induced signaling pathway10.1093/rb/rbaa004 ↗
30. A bioceramic scaffold composed of strontium-doped three-dimensional hydroxyapatite whiskers for enhanced bone regeneration in osteoporotic defects10.7150/thno.40103 ↗
31. Strontium functionalization of biomaterials for bone tissue engineering purposes: a biological point of view10.3390/ma15051724 ↗
32. Preparation and characterization of novel lithium magnesium phosphate bioceramic scaffolds facilitating bone generation10.1039/D2TB00471B ↗
33. The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment10.3390/ijms22126564 ↗
34. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis10.2165/10481900-000000000-00000 ↗
35. Strontium ranelate-loaded human hair keratin-hyaluronic acid hydrogel accelerates wound repair with anti-inflammatory and antioxidant properties10.1016/j.ijbiomac.2024.136536 ↗
36. Strontium attenuates hippocampal damage via suppressing neuroinflammation in high-fat diet-induced NAFLD mice
37. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration10.1016/j.actbio.2017.08.015 ↗
38. A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis
39. Low-dose strontium stimulates osteogenesis but high-dose doses cause apoptosis in human adipose-derived stem cells via regulation of the ERK1/2 signaling pathway10.1186/s13287-017-0726-8 ↗
40. Mechanisms of action and therapeutic potential of strontium in bone10.1007/s002230010055 ↗
41. Osteoblasts play key roles in the mechanisms of action of strontium ranelate10.1111/j.1476-5381.2009.00305.x ↗
42. Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells10.1016/j.bbrc.2012.01.088 ↗
43. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro10.1016/j.bone.2007.08.043 ↗
44. Dose-dependent effects of strontium ranelate on ovariectomy rat bone marrow mesenchymal stem cells and human umbilical vein endothelial cells10.7150/ijbs.16499 ↗
45. Strontium ions protect hearts against myocardial ischemia/reperfusion injury10.1126/sciadv.abe0726 ↗
46. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts10.1074/jbc.M111.251116 ↗
47. Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway10.1159/000204105 ↗
48. Low-dose strontium stimulates osteogenesis but high-dose doses cause apoptosis in human adipose-derived stem cells via regulation of the ERK1/2 signaling pathway10.1186/s13287-017-0726-8 ↗
49. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation10.1007/s11010-011-1034-8 ↗
50. Strontium regulates stem cell fate during osteogenic differentiation through asymmetric cell division10.1016/j.actbio.2020.10.030 ↗
51. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins10.1359/jbmr.070321 ↗
52. Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelate10.1111/j.1582-4934.2008.00673.x ↗
53. A review of the latest insights into the mechanism of action of strontium in bone
54. Evaluation of strontium-containing PCL-PDIPF scaffolds for bone tissue engineering: in vitro and in vivo studies10.1007/s10439-018-02183-z ↗
55. An akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts10.1074/jbc.M111.251116 ↗
56. Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts10.1371/journal.pone.0078612 ↗
57. A bioactive poly(ether-ether-ketone) nanocomposite scaffold regulates osteoblast/osteoclast activity for the regeneration of osteoporotic bone10.1039/D2TB01387H ↗
58. Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway10.1186/s13287-021-02372-z ↗
59. Anti-inflammatory and prochondrogenic in situ-formed injectable hydrogel crosslinked by strontium-doped bioglass for cartilage regeneration10.1021/acsami.1c20565 ↗
60. Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model10.1038/aps.2012.167 ↗
61. Supplementation of strontium to a chondrogenic medium promotes chondrogenic differentiation of human dedifferentiated fat cells10.1089/ten.tea.2014.0282 ↗
62. Effects of strontium on collagen content and expression of related genes in rat chondrocytes cultured in vitro10.1007/s12011-013-9640-9 ↗
63. Strontium-incorporated bioceramic scaffolds for enhanced osteoporosis bone regeneration10.1038/s41413-022-00224-x ↗
64. Wnt/β-catenin signaling plays an important role in the protective effects of FDP-Sr against oxidative stress induced apoptosis in MC3T3-E1 cell10.1016/j.bmcl.2016.08.043 ↗
65. Strontium ranelate ameliorates intervertebral disc degeneration via regulating TGF-131/NF-KB Axis10.7150/ijms.86665 ↗
66. High proportion strontium-doped micro-arc oxidation coatings enhance early osseointegration of titanium in osteoporosis by anti-oxidative stress pathway
67. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro10.1089/ten.2005.11.768 ↗
68. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2 ↗
69. Developing a strontium-releasing graphene oxide-/collagen-based organic inorganic nanobiocomposite for large bone defect regeneration via MAPK signaling pathway10.1021/acsami.8b22606 ↗
70. Promoting in vivo early angiogenesis with sub-micrometer strontium-contained bioactive microspheres through modulating macrophage phenotypes10.1016/j.biomaterials.2018.06.004 ↗
71. Strontium-doped gelatin scaffolds promote M2 macrophage switch and angiogenesis through modulating the polarization of neutrophils10.1039/D0BM02126A ↗
72. Strontium chondroitin sulfate/silk fibroin blend membrane containing microporous structure modulates macrophage responses for guided bone regeneration10.1016/j.carbpol.2019.02.068 ↗
73. Construction of wogonin nanoparticle-containing strontium-doped nanoporous structure on titanium surface to promote osteoporosis fracture repair
74. Calcium sensing receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: correlation with osteogenic differentiation10.1089/scd.2013.0627 ↗
75. The calcium-sensing receptor in bone-mechanistic and therapeutic insights10.1038/nrendo.2015.30 ↗
76. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells10.1006/bbrc.1999.0932 ↗
77. Is the calcium receptor a molecular target for the actions of strontium on bone?10.1007/s00198-002-1343-6 ↗
78. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor10.1016/j.bbrc.2004.08.209 ↗
79. Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis10.1016/j.pharmthera.2012.07.009 ↗
80. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways10.1074/jbc.M801668200 ↗
81. Wnt signaling: a key regulator of bone mass10.1016/S0070-2153(06)76004-5 ↗
82. Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus10.1093/emboj/20.15.4122 ↗
83. Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis10.1016/j.pharmthera.2012.07.009 ↗
84. Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers10.2174/092986712803414088 ↗
85. Strontium promotes osteogenic differentiation by activating autophagy via the the AMPK/mTOR signaling pathway in MC3T3-E1 cells
86. Enhancement of osteoporotic bone regeneration by strontium-substituted 45S5 bioglass via time-dependent modulation of autophagy and the Akt/mTOR signaling pathway10.1039/D0TB02991B ↗
87. Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-KB signaling pathway10.1016/j.bcp.2021.114734 ↗
88. Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-KB signaling pathway10.1016/j.bcp.2021.114734 ↗
89. Strontium ranelate inhibits osteoclastogenesis through NF-κB-Pathway-Dependent autophagy10.3390/bioengineering10030365 ↗
90. RNA-Seq investigation and in vivo study the effect of strontium ranelate on ovariectomized rat via the involvement of ROCK110.1080/21691401.2018.1433188 ↗
91. Strontium ranelate-induced anti-adipocytic effects are involved in negative regulation of autophagy in rat bone marrow mesenchymal stem cells10.1007/s00264-018-3960-5 ↗
92. Alkaline biodegradable implants for osteoporotic bone defects-importance of microenvironment pH10.1007/s00198-015-3217-8 ↗
93. Mechanically reinforced injectable bioactive nanocomposite hydrogels for in-situ bone regeneration10.1016/j.cej.2021.132799 ↗
94. Synergetic topography and chemistry cues guiding osteogenic differentiation in bone marrow stromal cells through ERK1/2 and p38 MAPK signaling pathway10.1039/C7BM01044C ↗
95. Osteoblasts play key roles in the mechanisms of action of strontium ranelate10.1111/j.1476-5381.2009.00305.x ↗
96. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways10.1074/jbc.M801668200 ↗
97. Strontium functionalized in biomaterials for bone tissue engineering: a prominent role in osteoimmunomodulation10.3389/fbioe.2022.928799 ↗
98. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis new insights into the associated signaling pathways10.1074/jbc.M801668200 ↗
99. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-B ligand in vivo
100. The bone remodelling cycle10.1177/0004563218759371 ↗